-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
A short video highlighting Volition Veterinary’s key moments from the 2022 London Vet Show. Hear from Dr. Sue Ettinger, aka Dr. Sue Cancer Vet, find out what veterinarians think about the Nu.Q® Vet Cancer test, listen to an update from Volition Veterinary Chief Operating Officer, Dr. Tom Butera, and much more.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields